These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3218007)

  • 1. [Criteria of the evaluation of the aggregative capacity of thrombocytes in patients with chronic renal failure during hemodialysis].
    Rud'ko IA; Kubatiev AA; Kulakov GP
    Urol Nefrol (Mosk); 1988; (3):48-53. PubMed ID: 3218007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
    Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
    Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathophysiology of platelet anomalies and its analysis. (3). Platelet aggregation, with special reference to clinical evaluation of the platelet aggregation in patients with diabetes mellitus and those under chronic hemodialysis].
    Matsuo T
    Rinsho Byori; 1983 Nov; 31(11):1168-75. PubMed ID: 6672292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of vitamin E on platelet function and anemia in patients on long-term hemodialysis].
    Janicka L; Dmoszyńska A; Ksiazek A; Kozioł M
    Pol Tyg Lek; 1988 Nov; 43(48):1557-8. PubMed ID: 3255907
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure].
    Rud'ko IA; Kubatiev AA; Tsalenchuk IaP
    Urol Nefrol (Mosk); 1993; (4):37-9. PubMed ID: 8310566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in platelet function in subjects with chronic renal insufficiency treated with periodical hemodialysis].
    Ferri GM; Taccone-Gallucci M; Bongiovanni P; Mazzarella V; Casciani CU
    Minerva Nefrol; 1981; 28(4):471-5. PubMed ID: 7339516
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of the platelet aggregation in patients with chronic renal insufficiency under extracorporeal dialysis].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1975 Oct; 97(9):509-12. PubMed ID: 1223580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet aggregation in chronic renal failure].
    Sánchez Casajús A; Lasierra J; Viladés E
    Rev Clin Esp; 1979 Apr; 153(2):137-41. PubMed ID: 482679
    [No Abstract]   [Full Text] [Related]  

  • 11. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local microviscosity of platelet membranes from patients with chronic renal failure on hemodialysis].
    Rud'ko IA; Chebotarev VN; Kubatiev AA
    Patol Fiziol Eksp Ter; 1994; (1):20-2. PubMed ID: 8183585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
    Vandelli L; Grosoli M; Lusvarghi E; Cenci AM; Campioli D; Grossi G
    Nephrol Dial Transplant; 1989; 4(12):1083-4. PubMed ID: 2517331
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in platelet aggregation in patients on a chronic intermittent dialysis program].
    Malý J; Erben J; Pecka M; Jebavý L; Bláha M; Siroký O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):295-306. PubMed ID: 6985168
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of uremic thrombocytopathy by hemodialysis].
    Frick U; Frick G; Vitu J; Wiedenhöft I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hemodialysis on the cyclic nucleotide content of thrombocytes in patients with chronic kidney failure].
    Rud'ko IA; Kulakov GP; Kubatiev AA
    Urol Nefrol (Mosk); 1987; (5):47-50. PubMed ID: 3424469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W; Dmoszyńska A; Sokołowska B
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythrocyte surface charges in patients with chronic kidney failure upon regular hemodialysis].
    Shemetov VD; Landar' VA; Gudim TV
    Urol Nefrol (Mosk); 1988; (6):58-9. PubMed ID: 3232268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.